1990
DOI: 10.1001/archsurg.1990.01410140115019
|View full text |Cite
|
Sign up to set email alerts
|

Carcinoma of the Gallbladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
21
0
1

Year Published

1993
1993
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 209 publications
(25 citation statements)
references
References 30 publications
3
21
0
1
Order By: Relevance
“…In the Mayo Clinic series [30], 36% of 11 1 patients underwent resection. Cholecystectomy was performed in 20% and radical cholecystectomy in 16%.…”
Section: Surgical Managementmentioning
confidence: 99%
See 1 more Smart Citation
“…In the Mayo Clinic series [30], 36% of 11 1 patients underwent resection. Cholecystectomy was performed in 20% and radical cholecystectomy in 16%.…”
Section: Surgical Managementmentioning
confidence: 99%
“…There were no long-term survivors. The Mayo Clinic data [30] suggest that although there was no survival difference in patients having radical cholecystectomy vs. cholecystectomy , overall there was a difference in favor of radical cholecystectomy in patients who had transmural extension or who had lymph node metastases (Table 11).…”
Section: Management Of Inapparent or Occultmentioning
confidence: 99%
“…However, the extent of surgical procedures remains controversial, particularly after incidental findings or in advanced stages of disease [13,21,22]. Some reasons for this are the lack of a uniform classification of staging systems in previous reports [23-25] and a different use of terms like "extended cholecystectomy" and "extended resection" which included various surgical procedures in some studies [7,23,26]. The 5- year survival rate following surgery for GBC is reported to be 5-13% in the recent literature [1,2,27] except a study of a small number of cases [2].…”
Section: Discussionmentioning
confidence: 99%
“…Während frühere Studien mit oftmals geringen Fallzahlen insbesondere bei fortgeschritten nodal-positiven Patienten keinen Überlebensvorteil nachweisen konnten und allenfalls für Patienten mit einem T4N0 ein Langzeitüberleben berichtet wurde, haben neueste Publikationen auch bei lokal fortgeschrittenen Tumoren mit einem reinhilären und/oder regionären LK-Befall (N1-/N2-Status) tumorfreie 5-Jahres-Überlebensraten von 22-25% berichtet [7,11] …”
Section: Vor Allem Patienten Im Stadium II Profitieren Von Der Radikaunclassified